On this page
For weight loss, the weekly shot has the most trial evidence behind it. Daily pills are an option too, and the right choice depends on the exact product, what it’s approved for, and what you’ll actually take.
The evidence gap is wide
Start with the shot. STEP 1 (Wilding et al., NEJM 2021) randomly assigned 1,961 adults to weekly brand-name semaglutide (Wegovy) 2.4 mg or placebo. After 68 weeks, people on Wegovy lost 14.9% of their body weight on average, versus 2.4% on placebo.
SELECT (Lincoff et al., NEJM 2023) followed 17,604 people with heart disease and no diabetes. They took the same weekly shot, brand-name semaglutide (Wegovy), for more than three years and had 20% fewer major heart events. It’s also the largest long-term safety study for this type of drug.
Brand-name tirzepatide (Zepbound) has the biggest weight-loss result (SURMOUNT-1: 20.9% at 15 mg over 72 weeks), and it only comes as a shot. Nearly everything we know about GLP-1 weight loss was learned through a needle.
The case for the pill is thinner. The Wegovy pill, 25 mg of semaglutide taken once a day, was approved based on the OASIS 4 trial. That evidence is small next to the record for the shot, since the two main shot trials alone enrolled close to 20,000 people. And no pill trial has shown the heart protection SELECT found for brand-name semaglutide (Wegovy) in people without diabetes. That trial hasn’t been run.
The pills aren’t all the same product. The Wegovy pill is FDA-approved semaglutide you take by mouth once a day, at 25 mg, for weight loss. The semaglutide pill sold in US pharmacies since 2019 is Rybelsus. It’s a type 2 diabetes drug that comes in 3, 7, and 14 mg. Those are diabetes doses. At that level, the weight change seen in the diabetes studies was modest: a few kilograms, nowhere near fifteen percent of body weight.
A pill has to survive your stomach
Semaglutide is a peptide, a chain of amino acids, which is exactly what your stomach is built to digest. The pill only works because it’s paired with a helper ingredient (SNAC). SNAC carries a small part of the dose through the stomach wall before your stomach breaks down the rest. Only about 1% of what you swallow reaches your blood.
Working around that creates rules. The Rybelsus label says to take it every morning on an empty stomach with no more than 4 ounces of water, then wait 30 minutes before you eat, drink, or take any other medicine. That’s 365 fasting windows a year. Each tablet follows its own label, so check yours.
The shot goes under the skin of your belly, thigh, or upper arm once a week. You can take it at any time of day, whether you’ve eaten or not. That’s fifty-two doses a year with no window to miss. Both forms act on the same receptor. Only the way the medicine gets in is different. How the drug works, the titration schedule, and the side effects are all covered in our GLP-1 guide.
Where the pill still fits
Preference matters, and fear of needles is real. A medicine you’ll take beats one you won’t. If you’d rather take a daily pill, that’s a fair choice. Make it with a clinician who can compare the exact products and the evidence behind each.
For a sense of scale, the shot uses a short, thin needle that goes just under the skin. Site reactions are usually mild and stay in one spot.
The practical answer
- The evidence: For weight loss, the weekly shot has far more trial evidence behind it than the pill, with larger trials and longer follow-up.
- The labels: The Wegovy pill is approved for weight loss. Rybelsus, the pill that’s been around longest, is approved for type 2 diabetes and not for weight loss.
- Our position: The weekly shot has the deepest evidence. A daily pill is a fair choice if you prefer it. Decide with your clinician.
Oral options are changing fast. Ask your prescriber which tablets are approved right now, what each one is approved for, and how its evidence compares with the shot.
Getting a GLP-1 through Zappy
If you’d rather take a pill, Zappy offers the Wegovy pill, the FDA-approved daily tablet. For a weekly shot, Zappy offers brand-name Wegovy and compounded semaglutide. Compounded semaglutide is made by LegitScript-verified 503A US pharmacies. Compounded medicines are not FDA-approved, and they are not a generic or equivalent of any brand-name drug. Zappy is cash-pay, and you can use FSA or HSA funds. Current prices are on each treatment page.
The five-minute quiz tells you whether you’re a candidate, and a clinician reviews every intake within 24 hours. That screening matters. GLP-1s carry a boxed warning for thyroid C-cell tumors. You shouldn’t take them if you or a family member has had medullary thyroid carcinoma or MEN 2. A history of pancreatitis calls for caution, and they aren’t used in pregnancy. Your dose is decided with the clinician, and not by a marketing page, including ours.
